Accelerated Major Singlet Metabolite Mapping in Human Brain Using Nonwater/Fat‐Suppressed Ultrashort‐TR FID‐MRSI With FID‐Encoded IDEAL
NMR in Biomedicine · 2026-12 · 39 (12)
DOI: 10.1002/nbm.70436 ↗Kurz gefasst
Fachartikel in der Zeitschrift NMR in Biomedicine, online erschienen am 17.11.2026. Verfasst von Joon Jang und 2 weiteren Autor:innen. Die Arbeit nennt 85 Literaturangaben. Gefördert von: National Research Foundation of Korea, Seoul National University Hospital.
Abstract (Originalsprache)
Free‐induction‐decay MR spectroscopic imaging (FID‐MRSI) with LCModel is a well‐established, rapid brain metabolite mapping method. However, multislice whole brain coverage still entails substantial acquisition time. To enable water‐referenced absolute mapping of the major brain singlets (total choline/creatine/N‐acetylaspartate [tCho/tCr/tNAA]) with substantially reduced scan time, we developed nonwater/fat‐suppressed ultrashort‐TR FID‐MRSI (uMRSI) combined with FID‐encoded Iterative Decomposition with Echo Asymmetry and Least‐squares estimation (IDEAL), a least‐squares chemical shift separation framework using uniformly sampled FID points as temporal encodings at 3.0 T. The proposed uMRSI used only 128 FID points shortening TR to 80 ms (vs. 470 ms for conventional FID‐MRSI [cMRSI]), yielding 10.58× shorter acquisition for water‐referenced quantification. To reduce bias in major singlet quantification from nonnegligible spectral contributions, the FID‐encoded IDEAL signal model also included glutamine‐glutamate complex (Glx) and myo‐inositol (mI) as singlet surrogates, in addition to tCho, tCr, and tNAA. Unsuppressed water and fat were suppressed using an orthogonality‐based subspace‐projection framework. Macromolecule (MM) basis functions were parameterized from metabolite‐nulled data and incorporated into a two‐stage FID‐encoded IDEAL scheme that jointly estimated metabolite amplitudes, MM contributions, and local field offset. Phantom validation used healthy adult‐range metabolite concentrations with added simulated MM; in vivo evaluation ( n = 15) compared uMRSI + FID‐encoded IDEAL with cMRSI + LCModel. The theoretical number of signal averages (NSA) approached the maximum for the five modeled metabolites. In phantom, major singlets showed low mean absolute percentage error (MAPE; 12.73% ± 3.76%) and Cramér‐Rao lower bound (CRLB; 5.50% ± 1.80%), despite visually noticeable frequency‐domain residuals. In vivo, tCho/tCr/tNAA maps showed moderate agreement versus cMRSI + LCModel (structural similarity index measure [SSIM] = 0.71/0.82/0.87; r = 0.67/0.69/0.62 [all p < 0.001]) with small Bland–Altman biases (−0.42/−1.20/−1.98 mM). The proposed uMRSI + FID–encoded IDEAL has potential for further accelerated, water‐referenced absolute mapping of the major brain singlets at 3.0 T.
Förderung
- National Research Foundation of Korea
- Seoul National University Hospital
Zitieren
APA
Jang, J., Kim, J., & Kim, H. (2026). Accelerated Major Singlet Metabolite Mapping in Human Brain Using Nonwater/Fat‐Suppressed Ultrashort‐TR FID‐MRSI With FID‐Encoded IDEAL. NMR in Biomedicine, 39(12). https://doi.org/10.1002/nbm.70436
Vancouver
Jang J, Kim J, Kim H. Accelerated Major Singlet Metabolite Mapping in Human Brain Using Nonwater/Fat‐Suppressed Ultrashort‐TR FID‐MRSI With FID‐Encoded IDEAL. NMR in Biomedicine. 2026;39(12). doi:10.1002/nbm.70436
BibTeX
@article{Jang2026,
author = {Jang, Joon and Kim, Ji‐hoon and Kim, Hyeonjin},
title = {Accelerated Major Singlet Metabolite Mapping in Human Brain Using Nonwater/Fat‐Suppressed Ultrashort‐TR FID‐MRSI With FID‐Encoded IDEAL},
journal = {NMR in Biomedicine},
year = {2026},
volume = {39},
number = {12},
doi = {10.1002/nbm.70436}
}
EUVIMED